Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 768-773

  Tonyali, Onder ^a   Coskun, Ugur ^a   Yildiz, Ramazan ^a   Karakan, Tarkan ^a   Demirci, Umut ^a   Akyurek, Nalan ^a   Benekli, Mustafa ^a   Buyukberber, Suleyman ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Gastrointestinal stromal tumors; Imatinib mesylate; Liver failure; Prednisolone; Toxic hepatitis

Indexed keywords

IMATINIB; LIVER ENZYME; PREDNISOLONE;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; INFLAMMATION; JAUNDICE; LIVER BIOPSY; LIVER CELL; LIVER CONGESTION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER SINUSOID; LIVER TOXICITY; PRIORITY JOURNAL; TREATMENT RESPONSE; VENULE;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; INTESTINAL NEOPLASMS; LIVER; LIVER FAILURE; MIDDLE AGED; PERITONEAL NEOPLASMS; PIPERAZINES; PREDNISOLONE; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLES;

EID: 77956945030     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9284-y     Document Type: Article

References (21)

1. SG O'Brien, et al. 2003 Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N Engl J Med 348 994 1004 10.1056/NEJMoa022457 12637609 (Pubitemid 36302244)
2. GD Demetri, et al. 2002 Efficacy and safety of imatinib mesylate in advanced gastro-intestinal stromal tumors N Engl J Med 347 472 480 10.1056/NEJMoa020461 1:CAS:528:DC%2BD38XmtV2nt7s%3D 12181401 (Pubitemid 34879334)
3. BJ Druker, et al. 2001 Efficacy and safety of a specific inhibitor of the BCRABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037 10.1056/NEJM200104053441401 1:CAS:528:DC%2BD3MXivFGnu70%3D 11287972 (Pubitemid 32267972)
4. MH Cohen, et al. 2002 Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia Clin Cancer Res 8 935 942 1:CAS:528:DC%2BD38XksVSqtbs%3D 12006504
5. F Fuster L Medina R Vallansot M Granell M Brugeuera 2007 Imatinib induced toxic hepatitis: description of two cases and review of the literature Gastroenterol Hepatol 30 525 530 10.1157/13111687 17980129
6. M Talpaz, et al. 2002 Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study Blood 99 1928 1937 10.1182/blood.V99.6.1928 1:CAS:528:DC%2BD38XitF2nt74%3D 11877262 (Pubitemid 34525471)
7. TJ Cross C Bagot B Portmann J Wendon D Gillett 2006 Imatinib mesylate as a cause of acute liver failure Am J Hematol 81 189 192 10.1002/ajh.20486 16493605
8. NU Lin, et al. 2003 Fatal hepatic necrosis following Imatinib mesylate therapy Blood 102 3455 3456 10.1182/blood-2003-07-2323 1:CAS:528: DC%2BD3sXoslersL0%3D 14568907 (Pubitemid 37314789)
9. E Ridruejo, et al. 2007 Imatinib-induced fatal acute liver failure World J Gastroenterol 13 6608 6611 1:CAS:528:DC%2BD1cXhslSksbs%3D 18161937
10. K Ikeda, et al. 2006 Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment Leuk Lymphoma 47 155 157 10.1080/14639230500236818 1:CAS:528:DC%2BD2MXht1Kntb%2FF 16321842 (Pubitemid 43101740)
11. TJ Thia HH Tan TH Chuah WC Chow HF Lui 2008 Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection Singapore Med J 49 e86 e89 1:STN:280: DC%2BD1c3gsVCgug%3D%3D 18362995
12. K Ohyashiki, et al. 2002 Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis Leukemia 16 2160 2161 10.1038/sj.leu.2402702 1:CAS:528: DC%2BD38XnsVamsb4%3D 12357373 (Pubitemid 35203464)
13. C James H Trouette G Marit P Cony-Makhoul FX Mahon 2003 Histological features of acute hepatitis after imatinib mesylate treatment Leukemia 17 978 979 10.1038/sj.leu.2402910 1:STN:280:DC%2BD3s3ivVOktg%3D%3D 12750713
14. WS Ayoub, et al. 2005 Imatinib (Gleevec)-induced hepatotoxicity J Clin Gastroenterol 39 75 77 1:CAS:528:DC%2BD2cXhtVOqs77J 15599217
15. S Kikuchi, et al. 2004 Severe hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes Leuk Lymphoma 45 2349 2351 10.1080/10428190412331272721 15512829 (Pubitemid 39504334)
16. AL Mindikoglu, et al. 2007 Imatinib mesylate (glevec) hepatotoxicity Dig Dis Sci 52 598 601 10.1007/s10620-006-9117-1 17219077 (Pubitemid 46202847)
17. E Al Sobhi Z Zahrani E Zevallos A Zuraiki 2007 Imatinib-induced immune hepatitis: case report and literature review Hematology 12 49 53 10.1080/10245330600937929 17364993 (Pubitemid 46394870)
18. A Pariente, et al. 2006 Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour Eur J Gastroenterol Hepatol 18 785 787 10.1097/01.meg.0000216941.42306.0e 16772838
19. JH Kong, et al. 2007 Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia Acta Haematol 118 205 208 10.1159/000111092 1:CAS:528:DC%2BD1cXht1Sgt7c%3D 18030002 (Pubitemid 351182631)
20. V Dhalluin-Venier, et al. 2006 Imatinib mesylate-induced acute hepatitis with autoimmune features Eur J Gastroenterol Hepatol 18 1235 1237 10.1097/01.meg.0000243867.56454.13 1:CAS:528:DC%2BD28XhtVKjtLvN 17033447 (Pubitemid 44563886)
21. D Ferrero, et al. 2006 Corticosteroids can reverse severe imatinib-induced hepatotoxicity Haematologica 91 6 Suppl 357